RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding RAPT Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 94 | −8 |
| Shares | 31.8M | 2.44M | 29.8M | +430.7K (+1.5%) |
| Value | $97.0M | $7.44M | $59.9M | −$29.7M (−33.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 2,498,521 | $5.02M | 0.00% |
| Nomura Holdings Inc | 84,184 | $169.2K | 0.00% |
| Bridgeway Capital Management, LLC | 75,000 | $150.8K | 0.00% |
| Readystate Asset Management LP | 18,074 | $36.3K | 0.00% |
| Group One Trading, L.P. | 11,030 | $22.2K | 0.00% |
| Jefferies Financial Group Inc. | 10,450 | $21.0K | 0.00% |
| SG Americas Securities, LLC | 10,608 | $21.0K | 0.00% |
| Fortitude Family Office, LLC | 959 | $1.93K | 0.00% |
| CoreCap Advisors, LLC | 629 | $1.26K | 0.00% |
| Sterling Capital Management LLC | 95 | $191 | 0.00% |
| Capital Performance Advisors LLP | 34 | $68 | 0.00% |
Sold out (19)
Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Ardsley Advisory Partners LP | 500,000 | $1.52M |
| Squarepoint Ops LLC | 107,994 | $329.4K |
| Norges Bank | 100,300 | $305.9K |
| Graham Capital Management, L.P. | 94,680 | $288.8K |
| AQR Capital Management LLC | 88,373 | $269.5K |
| Affinity Asset Advisors, LLC | 75,000 | $228.8K |
| Verition Fund Management LLC | 55,825 | $170.3K |
| Thrivent Financial for Lutherans | 53,993 | $164.0K |
| Gsa Capital Partners LLP | 36,654 | $112.0K |
| XTX Topco Ltd | 35,480 | $108.2K |
| Stifel Financial Corp | 17,421 | $53.1K |
| Cerity Partners LLC | 10,546 | $32.2K |
| Point72 (DIFC) Ltd | 8,697 | $26.5K |
| Point72 Asia (Singapore) Pte. Ltd. | 4,599 | $14.0K |
| Allspring Global Investments Holdings, LLC | 914 | $2.79K |
| Smartleaf Asset Management LLC | 257 | $742 |
| Advisor Group Holdings, Inc. | 90 | $275 |
| Nisa Investment Advisors, LLC | 39 | $119 |
| Quadrant Capital Group LLC | 38 | $116 |
Not filed for Q3 2024 yet (1)
Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 2,439,830 | $7.44M |